IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Inogen Inc (INGN)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Latest Price
$5.20
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
6.43
P/B Ratio
0.81

Valuation metrics

adjust assumptions →
Base FCF: $10M (median of recent 5yr)
Growth: -14%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$5.54
+7% upside

Institutional Ownership

67.7% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.1.75M$11.0M6.54%+101.9K2026-06-30
ARMISTICE CAPITAL, LLC1.10M$7.0M4.10%-104.0K2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC1.04M$6.0M3.88%+1.6K2026-06-30
AMERIPRISE FINANCIAL INC983.0K$6.0M3.68%+123.5K2026-06-30
AQR CAPITAL MANAGEMENT LLC937.3K$6.0M3.51%+510.2K2026-06-30
DAFNA Capital Management LLC845.2K$5.0M3.16%--2026-06-30
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP743.3K$4.0M2.78%+157.1K2026-06-30
MORGAN STANLEY646.3K$4.0M2.42%+105.1K2026-06-30
GEODE CAPITAL MANAGEMENT, LLC641.5K$4.0M2.40%+28.0K2026-06-30
STATE STREET CORP591.9K$3.0M2.21%+18.7K2026-06-30
View all institutional holders →